Pharmaceutical composition for treating swine streptococcosis

A technology of Streptococcus suis and its composition, which is applied in the field of pharmaceutical preparation, can solve the problems of high antibiotic residues and antibiotic resistance, and achieve the effects of no toxic side effects, convenient carrying and taking, and fast onset of effect

Inactive Publication Date: 2017-05-31
郑州欧印数字科技有限公司
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although this drug treatment has a certain effect, the problem is that the residual amount of antibiotics is high.
Antibiotics may enter the human body with pork, and it is easy to produce antibiotic resistance to the human body

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0015] A pharmaceutical composition for treating streptococcosis suis, the main raw materials in parts by weight are: 5 parts of urotropine, 2 parts of toosendanin, 9 parts of evodia lactone, 25 parts of gomisin G, 15 parts of colchicine 2 parts, 2 parts of 11-keto-boswellic acid, 6 parts of ephedrine, 0.5 parts of epoxy caperitol, 8 parts of isoforsythiaside, and 2 parts of taraconitamine.

[0016] A kind of preparation method of the pharmaceutical composition for the treatment of suis streptococcosis, concrete steps are:

[0017] First, in the pharmaceutical-grade clean area, weigh urotropine, toosendanin, rutaecarlide, gomisin G, colchicine, 11-ketoboswellic acid, ephedrine, epoxy continuation Caperic alcohol, isoforsythiaside, and taraconitamine, sieved, mechanically mixed, added ultrapure water, placed in a pharmaceutical mixer, mixed for 4 minutes, controlled RSD≤5%, after mixing, compressed into tablets and dried at low temperature , the temperature is controlled at 4 ...

Embodiment 2

[0019] A pharmaceutical composition for treating streptococcosis suis, the main raw materials in parts by weight are: 8 parts of urotropine, 3 parts of toosendanin, 9 parts of evodia lactone, 28 parts of gomisin G, and 18 parts of colchicine 2 parts, 2 parts of 11-keto-boswellic acid, 6 parts of ephedrine, 0.5 parts of epoxy caperitol, 8 parts of isoforsythiaside, and 2 parts of taraconitamine.

[0020] A kind of preparation method of the pharmaceutical composition for the treatment of suis streptococcosis, concrete steps are:

[0021] First, in the pharmaceutical-grade clean area, weigh urotropine, toosendanin, rutaecarlide, gomisin G, colchicine, 11-ketoboswellic acid, ephedrine, epoxy continuation Caperic alcohol, isoforsythiaside, and taraconitamine, sieved, mechanically mixed, added ultrapure water, placed in a pharmaceutical mixer, mixed for 4 minutes, controlled RSD≤5%, after mixing, compressed into tablets and dried at low temperature , the temperature is controlled a...

Embodiment 3

[0023] A pharmaceutical composition for treating streptococcosis suis, the main raw materials in parts by weight are: 10 parts of urotropine, 4 parts of toosendanin, 10 parts of evodia lactone, 29 parts of gomisin G, 19 parts of colchicine parts, 3 parts of 11-keto-boswellic acid, 8 parts of ephedrine, 0.9 parts of epoxy caperitol, 9 parts of isoforsythiaside, and 3 parts of taraconitamine.

[0024] A kind of preparation method of the pharmaceutical composition for the treatment of suis streptococcosis, concrete steps are:

[0025] First, in the pharmaceutical-grade clean area, weigh urotropine, toosendanin, rutaecarlide, gomisin G, colchicine, 11-ketoboswellic acid, ephedrine, epoxy continuation Caperic alcohol, isoforsythiaside, and taraconitamine, sieved, mechanically mixed, added ultrapure water, placed in a pharmaceutical mixer, mixed for 6 minutes, controlled RSD ≤ 5%, after mixing, pressed into tablets and dried at low temperature , the temperature is controlled at 6 D...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a pharmaceutical composition for treating swine streptococcosis. The pharmaceutical composition for treating the swine streptococcosis comprises the following raw materials by weight: 5-16 parts of urotropin, 2-6 parts of toosendanin, 9-10 parts of Dictamnolactone, 25-32 parts of Gomisin G, 15-23 parts of colchicines, 2-4 parts of 11-Keto frankincense acid, 6-10 parts of ephedrine, 0.5-1.4 parts of epoxy lathyrol, 8-9 parts of isoforsythiaside, and 2-4 parts of talatisamine. According to the understanding mechanism of the swine streptococcosis, the raw material components of the pharmaceutical are strictly selected to achieve the goal of comprehensive rehabilitation. The pharmaceutical has the characteristics of rapid effective speed, stable function, convenient carrying and administration, and no toxic and side effects for long-term administration.

Description

technical field [0001] The invention relates to the field of medicine preparation, in particular to a pharmaceutical composition for treating streptococcus suis. Background technique [0002] Streptococcus suis, also known as swine bloody dysentery, is a serious intestinal infectious disease caused by Treponema suis. The main clinical symptoms are severe mucous hemorrhagic diarrhea, and the acute type is mainly hemorrhagic diarrhea. , subacute and chronic mainly with mucus diarrhea for a period of time. The autopsy pathological features were catarrhal, hemorrhagic and necrotic inflammation in the large intestine mucosa. Under natural circumstances, only pigs are sick, and pigs of various ages and varieties can be infected, but the main damage is 2-3 month-old piglets; the morbidity and mortality of young pigs are higher than that of large pigs; sick pigs and Carriers are the main source of infection, and the occurrence of the disease has no obvious seasonality; due to the ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/53A61K31/58A61K31/585A61K31/36A61K31/165A61K31/56A61K31/137A61K31/336A61P31/04A61P1/12
CPCA61K31/53A61K31/137A61K31/165A61K31/336A61K31/36A61K31/56A61K31/58A61K31/585
Inventor 不公告发明人
Owner 郑州欧印数字科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap